LabStyle Innovations, Creator of Dario™ Diabetes mHealth Solution Presentation Now Available for On-Demand viewing at RetailInvestorConferences.com - myFOXnepa.com

LabStyle Innovations, Creator of Dario™ Diabetes mHealth Solution Presentation Now Available for On-Demand viewing at RetailInvestorConferences.com

Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact pressreleases@worldnow.com.

SOURCE LabStyle Innovations, Inc.

LabStyle invites individual and institutional investors to attend interactive real-time presentation on how mHealth can make life easier for people with diabetes and other chronic diseases

NEW YORK, June 9, 2014 /PRNewswire/ -- LabStyle Innovations Corp. (OTCQB:DRIO), developer of the Dario™ Diabetes mHealth Solution, announced that the June 5th presentation from President and Chief Executive Officer, Mr. Erez Raphael, is now available for on-demand viewing at RetailInvestorConferences.com.

LINK: http://retailinvestorconferences.com > red "register/ watch event now" button

LabStyle Innovations' presentation will be available 24/7 for 90 days. Investors and advisors may download shareholder materials from the "virtual trade booth" for the next three weeks.

About LabStyle Innovations

LabStyle Innovations Corp. (OTCQB:DRIO) develops and commercializes patent-pending technology providing consumers with laboratory-testing capabilities using smart mobile devices. LabStyle's flagship product is the Dario™ personalized Diabetes mHealth Solution.   Dario™ received CE mark certification in September 2013 and began a world rollout of the Dario™ mobile application in select countries in December 2013, and initial launches of the full Dario™ solution have commenced in Europe, Australia and New Zealand during 2014.  LabStyle filed a Premarket Notification Application, also known as a 510(k), with the US Food and Drug Administration (FDA) for the Dario™ smart meter (Dario™ Blood Glucose Monitoring System) in December 2013.  LabStyle is pursuing patent applications in multiple areas covering the specific processes related to blood glucose level measurement as well as more general methods of rapid tests of body fluids using mobile devices and cloud-based services, and in April 2014 LabStyle received a Notice of Allowance for a U.S. patent covering core functions of the Dario™ Blood Glucose Monitoring System. For more information: www.mydario.com and http://mydario.investorroom.com.

About RetailInvestorConferences.com

Since 2010, RetailInvestorConferences.com, created by BetterInvesting (NAIC) PR Newswire and MUNCmedia, has been the only monthly virtual investor conference series that provides an interactive forum for presenting companies to meet directly with retail investors using a graphically-enhanced online platform.

Designed to replicate the look and feel of location-based investor conferences, Retail Investor Conferences unites PR Newswire's leading-edge online conferencing and investor communications capabilities with BetterInvesting's extensive retail investor audience network.

©2012 PR Newswire. All Rights Reserved.